ZEB2 and breast cancer: To characterize the EMT phenotype of breast cancer cell line HMLER, the researchers consider the expression of the CDH1 and EPCAM genes as epithelial, hence, early traits, and VIM and ZEB2 as mesenchymal and, therefore more later traits [8].